Quantitative Dual-Isotope Planar Imaging of Thorium-227 and Radium-223 Using Defined Energy Windows by Murray
Quantitative Dual-Isotope Planar Imaging of Thorium-227
and Radium-223 Using Defined Energy Windows
Iain Murray,1 Bruno Rojas,1 Jonathan Gear,1 Ruby Callister,1 Adriaan Cleton,2 and Glenn D. Flux1
Abstract
Introduction: Thorium-227 is an alpha-emitting radioisotope with potential therapeutic applications in targeted
alpha therapy. Thorium-227 decays to Radium-223, which may have an independent biodistribution to that of
the parent Thorium-227 radiopharmaceutical. Quantitative in vivo imaging with sodium iodide (NaI) detectors
is challenging due to cross-talk between neighboring gamma photopeaks as well as scattered gamma photons.
The aim of this work was to validate the use of a spectral analysis technique to estimate the activity of each
isotope within a region of interest applied to a pair of conjugate view planar acquisitions, acquired at multiple
energy windows.
Methods: Energy spectra per unit activity arising from unscattered Thorium-227 photons and Radium-223
photons as well as from scattered photons were modeled. These spectra were scaled until the combination of
these component spectra resulted in the closest match to the measured data in four energy windows.
Results: Measured estimates of activity followed the known decay curves in phantoms representative of a
human torso. The mean errors in estimating Thorium-227 and Radium-223 were 5.1% (range -8.0% to 40.0%)
and 3.4% (range -50.0% to 48.7%), respectively. The differences between the integrals of the theoretical and
estimated time activity curve were <10% for both Thorium-227 and Radium-223.
Conclusion: Gamma camera quantification of Thorium-227 and Radium-223 can be achieved by using multiple
energy window acquisitions.
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Introduction
Thorium-227 (
227Th) is an alpha-emitting radionuclide
with a half-life of 18.7 days. 227Th decays to Radium-
223 (223Ra), which decays by a series of further alpha and
beta emissions to the stable isotope Lead-207, with a half-life
of 11.4 days (Table 1).1 223Ra is a calcium analogue that
demonstrates increased uptake in regions of high osteoblastic
activity. This has led to routine clinical application in the
treatment of metastatic castrate-resistant prostate cancer pa-
tients with bone metastases and no visceral metastases.2
223Ra also emits a number of gamma photons and several
studies have demonstrated that gamma camera imaging may
be used to quantitatively assess the biodistribution of 223Ra
in vivo, both to normal organs and to target lesions.3–6
Although 223Ra can be used to treat bone metastases,
223Ra ions do not specifically target cancer cells and
therefore cannot be used to treat soft tissue metastases. For
radionuclides to be taken up by specific cells, the radionu-
clide must be labeled to a targeting agent such as an anti-
body or antibody fragment that has a specific affinity to a
biological target presented by the cell.
227Th has been successfully labeled to a number of such
antibodies.7–14 However, 223Ra does not easily form stable
complexes.15 Therefore, it is possible that after the decay of
227Th to 223Ra, 223Ra may dissociate from the antibody
complex, resulting in free 223Ra ions with a biodistribution
independent of the 227Th-labeled antibody. As these 227Th
compounds enter clinical trials, there is a need to assess
these potentially independent biodistributions.
Dual-isotope imaging can be performed with gamma
cameras by using separate energy windows associated with
the photopeaks of the different isotopes. In the case of these
trials, a multicenter imaging protocol using the energy
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windows detailed in Table 2 has been implemented. The
rationale for these windows is discussed by Larsson et al.16
However, downscatter and cross-talk between neighboring
photopeaks, due to the finite energy resolution of sodium
iodide (NaI) detectors, mean that quantitation of 227Th and
223Ra requires careful analysis of the photons collected in
these windows.
The energy spectrum of measured counts in response to
multiple radionuclides can be considered to be the weighted
sum of a number of basis functions.17 Each function is
representative of the energy spectrum associated with a
subclass of photons, for example, primary photons from an
isotope of particular interest.
The aim of this article is to describe and validate a
spectral analysis methodology to process the data from
multiple energy windows detecting 223Ra and 227Th emis-
sions to determine the activity of each isotope within a
defined region of interest (ROI).
Methods
Spectral analysis methodology
Gamma photons are emitted at discrete energies with
probabilities of emission per unit decay, n(E), characteristic
of a particular radioisotope. The measured count-rate in the
presence of unknown activities of 227Th and 223Ra (ATh227
and ARa223) can be represented as a continuous function of
energy, C(E) obtained from a weighted summation of
component energy spectra. The component energy spectra
represent count-rates per unit activity arising from unat-
tenuated primary photons emitted by either 223Ra and its
daughter isotopes, PRa223(E), or by
227Th, PTh227(E), as well
as photons originally arising from either isotope that are
scattered within the patient or the gamma camera collimator
before detection, SRa223(E) and STh227(E) respectively.
Equation 1
C Eð Þ¼ATh227PTh227 Eð ÞþARa223PRa223 Eð Þ
þB ATh227STh227 Eð ÞþARa223SRa223 Eð Þð ÞþBkg Eð Þ
It is expected that the number of scattered photons is
proportional to the activity of the isotopes. In Equation 1,
the term B is a constant of proportionality describing this
relationship. Bkg (E) represents a contribution to the count-
rate per unit activity from background radiation. For the
purposes of this investigation, it was assumed that this could
be determined experimentally. If the functions PTh227,
PRa223, STh227, and SRa223 are known, then it can be seen that
the relative weight of these component functions can be
adjusted until a best fit to the background-corrected mea-
sured total counts is obtained. This section describes the
derivation of these functions accounting for patient-specific
attenuation, modeling of the thallium doped sodium iodide
(NaI(Tl)) energy resolution, and the absolute sensitivity of
the gamma camera.
A source of radiation within an attenuating medium
(assumed to be water) of thickness x and attenuation co-
efficient l was considered within the field of view of a
double-headed gamma camera. The gamma camera heads
comprised NaI(Tl) crystals with a thickness t, as well as
collimators characterized by parallel holes of diameter D,
length L, separated by lead septa of thickness T (Fig. 1).
The conjugate view technique is commonly used to
quantify activity from planar images. Background-corrected
count-rates are measured both anterior (Cant(E)) and poste-
rior (Cpost(E)) to the patient. The background corrected
geometric mean count-rate, CGM Eð Þ, is defined as the square
root of the product of these measurements.
Equation 2
CGM Eð Þ ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
Cant Eð ÞCpost Eð Þ
 q
¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
C0 Eð Þe  l Eð Þdð ÞC0 Eð Þe  l Eð Þ x dð Þð Þ
p
¼C0 Eð Þel Eð Þx=2
where l(E) is the energy-specific attenuation coefficient of
water and C0 Eð Þ is the theoretical count-rate in the absence
of attenuation.
Table 1. 227Th Decay Scheme: Photon Energies with an Abundance >1% Are Shown
Decay
Decay
mode Half-life Principal photon energies (keV) (% abundance)
227Th/223Ra A 18.7 days 12.3 (21.0), 50.1 (8.0), 79.7 (1.7), 85.4 (1.2), 88.5 (2.0), 94.0 (1.4),
210.7 (1.1), 236.0 (12.3), 256.3 (7.0), 286.1 (1.5), 300.0 (2.3),
304.5 (1.2) 329.9 (2.7), 334 (1.1)
223Ra/219Rn a 11.4 days 11.7 (25.0), 81.1 (15.0), 83.8 (24.9), 94.9 (11.3), 122.3 (1.2), 144.2 (3.2),
154.2 (5.6), 269.5 (13.7), 323.9 (3.9), 338.3 (2.8), 445.0 (1.3)
219Rn/215Po a 4.0 s 11.1 (1.1), 271.2 (10.8), 401.8 (6.4)
215Po/211Pb a 1.8 ms
211Pb/211Bi b 36.1 min 404.9 (3.8), 427.1 (1.8), 832.0 (3.5)
211Bi/207Tl a 2.1 min 10.3 (1.1), 72.9 (1.3), 351.1 (12.9)
207Tl/207Pb b 4.8 min
Table 2. Emissions Anticipated Within
Energy Windows
75–
100 keV
135–
165 keV
215–
260 keV
260–
285 keV
227Th primary
photons
X X
223Ra primary
photons
X X X
227Th scattered
photons
X X X
223Ra scattered
photons
X X X X
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The relationship between C0(E) and the source activity, A,
is determined by the probability of photon emission, n(E)
and the sensitivity, SGC, of the gamma camera.
Equation 3
C0 Eð Þ¼An Eð ÞSGC Eð Þ
Sensitivity is determined by the proportion of photons
entering the detector undergoing photoelectric absorption
ge Eð Þ as well as by the geometric efficiency of the colli-
mator, gG Eð Þ:
Equation 4
SGC Eð Þ¼ gG Eð Þge Eð Þ
Equation 5
gG Eð Þ¼ k
D2
L 2 = l( E )
 2 1þ TD
  2
Equation 6
ge Eð Þ¼ e sNaI Eð ÞtNaI
where k is a parameter dependent on the shape of the col-
limator holes, tNaI is the thickness of the gamma camera
crystal, and sNaI Eð Þ is the energy-dependent photoelectric
absorption coefficient of NaI(Tl).18
A model for the geometric mean count-rate per unit
activity arising from a radionuclide emitting gamma
photons, characterized by the spectrum, n(E), was gener-
ated by substituting Equations 3–6 into Equation 2 and
dividing by A.
Equation 7
CGM Eð Þ
A
¼ n Eð Þk D
2
L l( E ) =2
 2 1þ TD
  2
e sNaI Eð ÞtNaI e l Eð Þx=2
The energy resolution of the detector ER(E) was then
modeled by convolving the result of Equation 7 with a
Gaussian kernel to represent the measured geometric mean
count-rate per unit activity CGM_measured(E). The width of
the kernel was energy dependent, according to
Equation 8
r Eð Þ¼ ER Eð ÞE
2
ffiffiffiffiffiffiffiffiffi
2ln2
p
where
Equation 9
ER Eð Þ¼ER 140 keVð Þ 140
E
 w
and w was determined empirically by analyzing measure-
ments of energy resolution over multiple energies up to
511 keV. These measurements were made during acceptance
testing and were performed according to the NEMA-1 2012
standard.19 For the Siemens Intevo gamma camera, w was
found to be 0.09. Therefore,
Equation 10
PRa223 Eð Þ
¼ nRa223 Eð Þk D
2
L l Eð Þ
2
 2 1þ TD
 2
esNaI Eð ÞtNaI el Eð Þx=2
0
B@
1
CA
 1
r Eð Þ ffiffiffiffiffi2pp e
1
2
E¢E
rð Þ2
Equation 11
PTh227 Eð Þ
¼ nTh227 Eð Þk D
2
L l Eð Þ
2
 2 1þ TD
 2
esNaI Eð ÞtNaI el Eð Þx=2
0
B@
1
CA
 1
r Eð Þ ffiffiffiffiffi2pp e
1
2
E¢E
rð Þ2
The analytical modeling of unattenuated photons is
summarized in Figure 2A–C.
To derive the energy spectra components associated with
scattered photons, initial estimates of the basic functions
STh227(E), and SRa223(E) were generated from energy spectra
derived from Monte Carlo simulations (Fig. 2D). Simulations
were performed by using the SIMIND Monte Carlo soft-
ware20 of a water-filled cylindrical phantom (20 cm diameter
and 20 cm height) homogenously filled with either 227Th or
223Ra and placed 12 cm from a Siemens Symbia gamma
camera. Simulation details and input data for the simulated
collimator, crystal, backscatter layer, intrinsic energy, and
intrinsic spatial resolution were based on validated criteria
from an earlier study21 and are summarized in Table 3.
Events from primary, scattered, and septal penetrating
photons incident on the detector were binned according to
the interaction type. An energy spectrum of all detected
events less any event due to an attenuated primary photon
was recorded and used to define STh227(E) and SRa223(E).
Thus, the background-corrected geometric mean count-rate
in an acquired energy window
RE2
E1
CGMdE, was modeled by
weighting the photopeak and scatter energy spectra as follows.
FIG. 1. Schematic of source in gamma camera field of
view.
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FIG. 2. Modeling of primary photon and scattered photon energy spectrum components. (A) Energy spectra of emitted
photons from 227Th as well as from 223Ra and daughter isotopes. (B) Modeled geometric count-rate CGM(E) per unit activity
without consideration of energy resolution. (C) Modeled geometric count-rates PTh227(E) and PRa223(E) after convolution of
CGM/A with energy-dependent kernel modeling energy resolution. (D) Functions showing shape of scatter modeled within
gamma camera field of view. (E) A comparison of the gamma camera spectrum observed on day 9 of imaging the Jaszczak
phantom with the SIMIND simulation of a cylindrical phantom.
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Equation 12
ZE2
E1
CGMdE¼ATh227
ZE2
E1
PTh227dEþARa223
ZE2
E1
PRa223dE
þB ATh227
ZE2
E1
STh227dEþARa223
ZE2
E1
SRa223dE
0
B@
1
CA
The counts due to primary photons are assumed to be
directly proportional to the activity of the respective iso-
topes. In the case of the scattered photons, an explicit re-
lationship between the activity of an isotope and the number
of counts is not modeled. Instead, the parameter, B, is an
arbitrary coefficient used to scale a function describing the
presumed shape of the scatter spectra.
Emission spectra for all isotopes in the 227Th decay chain
were obtained from the Brookhaven database.1 The NIST
XCOM database was used to generate the attenuation co-
efficient of water as well as the attenuation due to photo-
electric absorption in NaI(Tl) over the relevant energy
ranges.22 Geometric sensitivity was defined for a high-
energy collimator parameterized by hexagonal holes of
4 mm diameter and 59.7 mm length with lead septa 2 mm
thick. The thickness of the NaI(Tl) detector was 9.5 mm.
Values of ATh227, ARa223, and B were obtained by using a
generalized reduced gradient algorithm23 (as implemented
within the solver function of MS Excel) to minimize the
sum of the squared differences between the background
corrected counts, and the modeled counts predicted by
Equation 12 in each of the acquired energy windows.
To facilitate empirical adaption of the scatter spectrum, a
modified scatter model was defined as follows:
Equation 13
ZE2
E1
S¢Ra223dE¼ vRa223 E1, E2
ZE2
E1
SRa223dE
ZE2
E1
S¢Th227dE¼ vTh227 E1, E2
ZE2
E1
STh227dE
Further, it was anticipated that a ‘‘one size fits all’’ scatter
model may not be appropriate for all scenarios. Experiments
were performed to test this assumption and to determine any
limits on the model used for activity estimation.
Phantom experiments
Two phantoms containing 227Th and 223Ra were used for
experiments. The first was a cylindrical Jaszczak type con-
taining two spheres of volume 14.6 and 83 mL, respectively
(Fig. 3). This was selected to be representative of a patient. The
smaller sphere was filled with 0.15 MBq 223Ra. A vial of 227Th
was received within 12 h of purification. This solution was used
to fill the 83 mL sphere with 0.54 MBq of 227Th, in addition to
0.014 MBq 223Ra. The same solution was also added to the
water-filled background compartment of the phantom such that
it contained 0.98 MBq 227Th, in addition to 0.025 MBq 223Ra
build-up. Therefore, the sphere to background ratio was*40.
Initial measurements of activity were made on a Capintec
CRC-15R calibrator before dispensing by weight. The cali-
brator had previously been set up with factors traceable to the
National Physics Laboratory (NPL) for both 223Ra and 227Th.24
The second phantom was a flat sensitivity phantom (100·
100· 5 mm) filled 9 days after purification with 1.33 MBq
227Th as well as the build-up associated with 0.92 MBq of 223Ra.
These activities were also confirmed with an NPL traceable
calibrator before filling the phantom. This phantom was used to
explore the effectiveness of the activity quantification.
The Bateman equations25 describing the relationship be-
tween the activity of a parent and daughter radionuclide were
used to calculate the activity in each phantom compartment
as a function of time. Phantoms were imaged on a double-
headed Siemens Intevo SPECT-CT system. The phantom
was positioned in the center of the imaging couch. Anterior
and posterior images were acquired for 20 min. Counts were
acquired at energy windows 75–100, 135–165, 215–260, and
260–285 keV. The image matrix was 64 · 64 (pixel size of
9.59· 9.59 mm). After planar imaging, a CT scout image
of the phantom was also acquired to estimate the amount of
attenuating tissue between the detector heads. The equivalent
thickness of water, x, within an ROI was derived from the
mean pixel value, p, of the scout image across that ROI
according to Equation 14. This equation provides an estimate
of the thickness in cm and was derived empirically by ana-
lyzing CT scout images of increasing thicknesses of solid
water and included the effect of the patient couch.
Equation 14
x¼ 0:22pþ 12
Background subtraction of the gamma camera images
was performed by using counts acquired over 9 h and scaled
to the phantom acquisition duration.
Table 3. SIMIND Input Parameters for Simulation
of a Siemens Symbia Gamma Camera Detector
SIMIND input Value
Crystal thickness (NaI(Tl)) 9.5 (mm)
Backscatter thickness (PMT) 11.0 (cm)
Cover thickness (Al) 0.1 (mm)
Gap between collimator and detector 1.0 (mm)
Energy resolution (@140 keV) 9.0 (%)
Intrinsic spatial resolution (@140 keV) 3.6 (mm)
Max. scatter order 10
Cut off energy 1.0 keV
NaI(Tl), thallium doped sodium iodide; PMT, photomultiplier tubes.
FIG. 3. Fused planar image of Jaszczak phantom con-
taining 227Th/223Ra anterior gamma camera image and CT
scout image.
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The Jaszczak phantom was initially imaged on the day of
filling (day 0). Further images were acquired at 1, 2, 3, 4, 7,
9, 11, 14, 16, 22, 24, and 29 days after filling.
The ROIs larger than the spheres themselves were placed
over the spheres within the body of the phantom to account
for spill out due to the partial volume effect. Identically
sized background ROIs were placed inferiorly to the spheres
to subtract counts arising due to underlying and overlying
activity within the background compartment. The same
process was used for all energy windows, views, and im-
aging time points.
Values for the set of scaling coefficients m were deter-
mined empirically by minimizing the difference between the
modeled counts (using the known activities as a priori in-
formation) and the measured counts arising from the larger
sphere. Data from day 0 were used to define the 227Th co-
efficients mTh227 75–100keV, mTh227 135–165keV, mTh227 215–260keV,
and mTh227 260–285keV at the point of minimal
223Ra build-up.
Data from day 14 were used to subsequently define the
223Ra coefficients mRa223 75–100keV, mRa223 135–165keV, mRa223
215–260keV, and mRa223 260–285keV. These coefficients were
subsequently applied during the analysis of data from all
other imaging time points.
Quantification accuracy was assessed at each time point
with respect to the known activities inside the spheres as
well as with respect to the integral of the known time ac-
tivity curve. The trapezoid integration method was used to
measure the cumulated activity.
Additional acquisitions were also obtained on day 2 and
29 with 4 cm solid water placed between the camera and the
Jaszczak phantom to test the activity estimation technique
on a phantom geometry not used for calibration purposes.
Pixel-by-pixel analysis of the anterior phantom images
acquired on day 22 was performed to demonstrate the po-
tential of the technique to produce distinct images of the
227Th and 223Ra distributions.
To investigate the effect of differing geometries, the
sensitivity phantom was imaged on day 9, 11, 16, 18, 22, 30,
34, and 42. The accuracy of the spectral analysis was tested
by comparing the activity estimates of at each time point
with the known activities in the phantom. On day 16, ad-
ditional images were acquired with slabs of solid water
ranging from 20 to 120 mm placed between the sensitivity
phantom and the gamma camera. The known activity of the
phantom was used to define scatter scaling coefficients
mRa223 75–100keV, mRa223 135–165keV, mRa223 215–260keV, and
mRa223 260–285keV as a function of the solid water thickness.
A further experiment was carried out to establish the ef-
fect of the distance between the sensitivity phantom and the
detector. Acquisitions were performed by using a sensitivity
phantom (containing 2.4 MBq 227Th and 1.4 MBq 223Ra) at
distances of 2, 5, 10, 15, and 20 cm between the phantom and
the detector above the couch. The posterior detector re-
mained in a fixed position. The counts in each window were
recorded. In addition, the variation in the activity estimated
was analyzed as a function of source to detector distance.
Results
Application of the spectral analysis methodology resulted
in estimates of activity for both 227Th and 223Ra with an
average difference between the known activity and the es-
timated activity of 5.1% (range -8.0% to 40.0%) and 3.4%
(range -50.0% to 48.7%), respectively (Fig. 4 and Table 4).
In the case of the smaller sphere that was filled only with
223Ra, estimates of 0 MBq 227Th were obtained in 11 out of
13 measurements. Assessments of the integral of the time
activity curves were accurate to within 10% of the ground
truth values.
FIG. 4. Measurements of 227Th and 223Ra within Jaszczak phantom spheres compared with ground truth activities.
(A) 14 mL sphere containing only 223Ra. (B) 83 mL sphere containing both 227Th and 223Ra.
Table 4. Percentage Errors in Activity
and Cumulated Activity Estimation
14 mL sphere 83 mL sphere
Error 227Th 223Ra 227Th 223Ra
Accuracy
of activity
estimate
n/a -6.8%
(range
-50.0%
to
10.9%)
5.1%
(range
-8.0% to
40.0%)
13.6%
(range
-15.0%
to
48.7%)
Accuracy of
cumulated
activity
estimate
n/a -8.3% 5.3% 7.3%
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The same methodology was also able to predict the ac-
tivity of the phantom inserts placed in a different geometry
to that used for calibration (Table 5). Despite the increased
attenuation and scatter, the average difference between the
known activity and the estimated activity was 8.3% (range
0.0% to 16.7%) and -11.0% (range -43.0% to 16.7%) for
227Th and 223Ra, respectively.
Pixel-by-pixel analysis of the acquired images could be
used to produce images of the distribution of each respective
isotope. This is demonstrated in Figure 5. The smaller
sphere containing 223Ra only is seen in all energy windows.
However, the sphere is not seen in the 227Th image.
Analysis of the flat sensitivity phantom data acquired
over multiple timepoints demonstrated a systematic un-
derestimation of both 227Th and 223Ra (21% and 33% re-
spectively) with respect to the known activities in the
phantom (Figure 6A).
The scaling coefficients required to correct this underes-
timate are demonstrated in Figure 6B as a function of the
amount of scatter material between the camera heads. As the
amount of scatter material increases, the coefficients be-
come consistent and appear to stabilize.
The effect of changing the distance between the sensi-
tivity phantom and the detector head is demonstrated in
Figure 7. At close distances there was an increase in the
counts detected within all energy windows. For estimation
of 223Ra activity, this did not result in a change in the es-
timated activity. For 227Th, a relative increase in the esti-
mated activity of up to 18% was observed as the distance
between the source and detector decreased.
Discussion
In this work, we have attempted to develop a methodol-
ogy to simultaneously quantify 227Th and 223Ra using planar
gamma camera imaging. This is challenging, primarily due
to the low activities administered to patients currently par-
ticipating in clinical trials of 227Th-antibodies. Planned
Table 5. Comparison of Measured Versus Known Activities for Case of Additional Attenuation
Time post
purification
(hours)
14 mL sphere 83 mL sphere
227Th activity (MBq) 223Ra activity (MBq) 227Th activity (MBq) 223Ra activity (MBq)
Expected Measured Expected Measured Expected Measured Expected Measured
Day 2 0.0 0.0 0.13 0.11 0.50 0.50 0.07 0.10
Day 29 0.0 0.0 0.03 0.04 0.18 0.15 0.24 0.20
FIG. 5. Demonstration of
pixel-by-pixel analysis re-
sulting in successful separa-
tion of 227Th and 223Ra
distributions.
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activities typically range between 1.5 MBq – 6.0 MBq. We
observed count-rates of *10.0 cps/MBq within the 215–
260 keV window due to 227Th photons and *70 cps/MBq
within the 75–100 keV window arising from 223Ra. Conse-
quently, long acquisition times are required. Current 227Th-
targeted alpha therapy study design allows for up to 1 h of
imaging time. Therefore, quantitation may be limited to organs
within the thorax, abdomen, and pelvis, which can typically be
covered by two fields of view. Low count-rates also lead to the
use of larger pixel sizes, resulting in poorer spatial resolution
and the increased potential for partial volume effects.
To quantify planar gamma camera images, the effect of
attenuation and scatter must be accounted for. In this work,
attenuation was modeled by an analytical model of photon
transport within the patient and the gamma camera. Con-
ventional scatter techniques such as the triple energy
FIG. 6. (A) Accuracy of activity estima-
tion for sensitivity phantom using proposed
scatter model. (B) Scaling coefficients mRa223
75–100keV, mRa223 135–165keV, mRa223 215–260keV,
and mRa223 260–285keV as a function of the
amount of attenuating water between gam-
ma camera heads.
FIG. 7. (A) Variation of acquired counts as a function of source to detector distance. (B) Estimated 227Th and 223Ra
activity as a function of source to detector distance.
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window correction are inappropriate due to the proximity of
the respective photopeaks of 227Th and 223Ra.
Instead, an empirical model of the shape of the scatter
spectra was scaled along with the modeled spectra of at-
tenuated 227Th and 223Ra photons to fit the measured data to
quantify planar conjugate images of 227Th and 223Ra dis-
tributions. Therefore, the accuracy with which the shape of
the scatter spectra is known will affect the accuracy of the
technique. The basis for our scatter spectra was a Monte
Carlo simulation of a cylindrical phantom. When applying
this model to a flat sensitivity phantom, systematic biases in
estimated activity were observed for both 227Th and 223Ra.
That is, the appropriateness of the scatter model to the pa-
tient anatomy must be considered. However, as increased
amounts of scatter material were placed around the sensi-
tivity phantom, the ad hoc changes to the scatter model
required for accurate quantification stabilized at thicknesses
above 100 mm. Indeed, when additional scatter material was
placed around the Jaszczak phantom, no such biases were
observed when estimating activity within the spheres. For
the adult population participating in these clinical trials,
patient thickness is expected to be greater than 100 mm.
There are a number of factors that lead to uncertainties in
the activity estimates produced by this method. The ana-
lytical model for primary photon detection relies in the first
instance on accurate knowledge of the gamma and x-ray
photon emissions associated with each isotope. We used the
Brookhaven database as a source of this information. More
recently, Collins et al. published revised figures detailing the
intensities of gamma photons emitted by 227Th.26 Compar-
ison of these measurements against the Brookhaven data-
base shows a discrepancy between 75–100 keV due to the
absence of x-ray emissions from the Collins publication but
minimal differences (<0.5%) when the convolved spectra is
integrated over the remaining energy windows.
Greater uncertainty is likely to result from the fitting of
the modeled data to the measured data. As described ear-
lier, these image acquisitions are characterized by low
counts, particularly within the higher energy windows.
Therefore, the uncertainty in the measured counts will
translate to an uncertainty in the isotope activities arising
from the model fit. A limitation of this work is that the
model fit was not weighted by the varying count uncer-
tainty across the different energy windows. For the pur-
poses of dosimetry, uncertainty in individual data
measurements may be mitigated by carrying out multiple
measurements over several time points. We observed dif-
ferences of up to 50% between the estimated activity and
the known activity but differences of <10% between the
estimated and the known time integrated activities.
We also observed that changes in septal penetration as
the distance between the source and the detector was varied
led to variations of up to 18% in estimates of 227Th activ-
ity, although estimation of 223Ra activity remained consistent.
For this reason, we would recommend the use of an HE col-
limator over an ME collimator to minimize septal penetration.
There remain limitations when quantifying planar gamma
camera data. Our phantom setup simulated a relatively high
organ to background ratio. Organs with activity concentra-
tions closer to background activity concentration may not
result in a clear signal that can be quantified. Further, organs
of interest often overlap, making separation of counts chal-
lenging.27 Therefore, further investigations should be made
into the potential of the technique when applied to SPECT
imaging. Despite the low activity administered to patients
receiving 223Ra, a number of investigations have reported that
SPECT imaging of alpha emitters is feasible.28–30
Conclusions
Quantification of 227Th and 223Ra activity in vivo is
possible by using multiple energy windows on a standard
double-headed gamma camera.
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